Drug Profile
AWD 12171
Latest Information Update: 23 Aug 2007
Price :
$50
*
At a glance
- Originator elbion
- Class
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Erectile dysfunction
Most Recent Events
- 02 Sep 2005 No development reported - Preclinical for Erectile dysfunction in Germany (unspecified route)
- 13 Mar 2002 AWD 12171 is available for licensing
- 07 Feb 2000 Preclinical development for Erectile dysfunction in Germany (Unknown route)